Literature DB >> 31609388

Polysomnographic features differentiating disorder of arousals from sleep-related hypermotor epilepsy.

Paola Proserpio1, Giuseppe Loddo2, Frederic Zubler3, Luigi Ferini-Strambi4, Laura Licchetta2,5, Francesca Bisulli2,5, Paolo Tinuper2,5, Elio Clemente Agostoni1, Claudio Bassetti3, Laura Tassi1, Veronica Menghi2, Federica Provini2,5, Lino Nobili1,6,7.   

Abstract

OBJECTIVE: The differential diagnosis between sleep-related hypermotor epilepsy (SHE) and disorders of arousal (DOA) may be challenging. We analyzed the stage and the relative time of occurrence of parasomnic and epileptic events to test their potential diagnostic accuracy as criteria to discriminate SHE from DOA.
METHODS: Video-polysomnography recordings of 89 patients with a definite diagnosis of DOA (59) or SHE (30) were reviewed to define major or minor events and to analyze their stage and relative time of occurrence. The "event distribution index" was defined on the basis of the occurrence of events during the first versus the second part of sleep period time. A group analysis was performed between DOA and SHE patients to identify candidate predictors and to quantify their discriminative performance.
RESULTS: The total number of motor events (i.e. major and minor) was significantly lower in DOA (3.2 ± 2.4) than in SHE patients (6.9 ± 8.3; p = 0.03). Episodes occurred mostly during N3 and N2 in DOA and SHE patients, respectively. The occurrence of at least one major event outside N3 was highly suggestive for SHE (p = 2*e-13; accuracy = 0.898, sensitivity = 0.793, specificity = 0.949). The occurrence of at least one minor event during N3 was highly suggestive for DOA (p = 4*e-5; accuracy = 0.73, sensitivity = 0.733, specificity = 0.723). The "event distribution index" was statistically higher in DOA for total (p = 0.012) and major events (p = 0.0026).
CONCLUSION: The stage and the relative time of occurrence of minor and major motor manifestations represent useful criteria to discriminate DOA from SHE episodes. © Sleep Research Society 2019. Published by Oxford University Press [on behalf of the Sleep Research Society]. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  disorder of arousal; parasomnia; sleep-related hypermotor epilepsy

Mesh:

Year:  2019        PMID: 31609388     DOI: 10.1093/sleep/zsz166

Source DB:  PubMed          Journal:  Sleep        ISSN: 0161-8105            Impact factor:   5.849


  6 in total

Review 1.  [Advances in sleep-related hypermotor epilepsy].

Authors:  Jiahui Xu; Bo Jin; Lisan Zhang; Shuang Wang
Journal:  Zhejiang Da Xue Xue Bao Yi Xue Ban       Date:  2020-08-25

2.  Commonalities and Differences in NREM Parasomnias and Sleep-Related Epilepsy: Is There a Continuum Between the Two Conditions?

Authors:  Carlotta Mutti; Giorgia Bernabè; Noemi Barozzi; Rosario Ciliento; Irene Trippi; Giuseppe Pedrazzi; Nicoletta Azzi; Liborio Parrino
Journal:  Front Neurol       Date:  2020-12-11       Impact factor: 4.003

Review 3.  Sleep and epilepsy: A snapshot of knowledge and future research lines.

Authors:  Lino Nobili; Birgit Frauscher; Sofia Eriksson; Steve Alex Gibbs; Peter Halasz; Isabelle Lambert; Raffaele Manni; Laure Peter-Derex; Paola Proserpio; Federica Provini; Al de Weerd; Liborio Parrino
Journal:  J Sleep Res       Date:  2022-04-29       Impact factor: 5.296

4.  Mental Activity During Episodes of Sleepwalking, Night Terrors or Confusional Arousals: Differences Between Children and Adults.

Authors:  Anna Castelnovo; Giuseppe Loddo; Federica Provini; Silvia Miano; Mauro Manconi
Journal:  Nat Sci Sleep       Date:  2021-06-21

5.  The additional diagnostic benefits of performing both video-polysomnography and prolonged video-EEG-monitoring: When and why.

Authors:  Melanie Bergmann; Elisabeth Brandauer; Ambra Stefani; Anna Heidbreder; Iris Unterberger; Birgit Högl
Journal:  Clin Neurophysiol Pract       Date:  2022-02-26

Review 6.  The Management and Alternative Therapies for Comorbid Sleep Disorders in Epilepsy.

Authors:  Weifeng Peng; Jing Ding; Xin Wang
Journal:  Curr Neuropharmacol       Date:  2021       Impact factor: 7.363

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.